Fresenius Medical Care AG KGaA Return on Tangible Equity 2010-2025 | FMS
Current and historical return on tangible equity values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Fresenius Medical Care AG KGaA Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.66B | $-0.49B | -83.03% |
| 2024-12-31 | $0.58B | $-0.84B | -63.08% |
| 2024-09-30 | $0.72B | $-0.82B | -69.23% |
| 2024-06-30 | $0.57B | $-1.05B | -47.61% |
| 2024-03-31 | $0.53B | $-0.98B | -36.02% |
| 2023-12-31 | $0.54B | $-1.28B | -32.59% |
| 2023-09-30 | $0.48B | $-1.50B | -26.40% |
| 2023-06-30 | $0.62B | $-2.07B | -31.60% |
| 2023-03-31 | $0.63B | $-1.79B | -32.90% |
| 2022-12-31 | $0.71B | $-1.96B | -37.45% |
| 2022-09-30 | $0.83B | $-2.07B | -42.34% |
| 2022-06-30 | $0.92B | $-1.80B | -46.12% |
| 2022-03-31 | $1.02B | $-1.76B | -47.28% |
| 2021-12-31 | $1.15B | $-2.18B | -50.31% |
| 2021-09-30 | $1.10B | $-2.21B | -47.82% |
| 2021-06-30 | $1.19B | $-2.50B | -48.89% |
| 2021-03-31 | $1.32B | $-2.22B | -54.48% |
| 2020-12-31 | $1.33B | $-2.29B | -52.31% |
| 2020-09-30 | $1.49B | $-2.75B | -57.66% |
| 2020-06-30 | $1.45B | $-2.41B | -58.32% |
| 2020-03-31 | $1.35B | $-2.71B | -54.25% |
| 2019-12-31 | $1.34B | $-2.48B | -58.21% |
| 2019-09-30 | $1.45B | $-2.34B | -85.76% |
| 2019-06-30 | $1.41B | $-2.41B | -118.13% |
| 2019-03-31 | $2.31B | $-2.01B | -314.92% |
| 2018-12-31 | $2.34B | $0.01B | -323.09% |
| 2018-09-30 | $2.32B | $-0.36B | -180.87% |
| 2018-06-30 | $2.35B | $-0.58B | -128.80% |
| 2018-03-31 | $1.46B | $-1.97B | -62.07% |
| 2017-12-31 | $1.45B | $-2.21B | -57.63% |
| 2017-09-30 | $1.38B | $-2.53B | -50.56% |
| 2017-06-30 | $1.35B | $-2.69B | -47.12% |
| 2017-03-31 | $1.34B | $-2.60B | -44.18% |
| 2016-12-31 | $1.24B | $-3.06B | -39.05% |
| 2016-09-30 | $1.17B | $-3.07B | -35.94% |
| 2016-06-30 | $1.10B | $-3.43B | -32.36% |
| 2016-03-31 | $1.05B | $-3.18B | -30.63% |
| 2015-12-31 | $1.03B | $-3.37B | -29.40% |
| 2015-09-30 | $1.05B | $-3.64B | -28.78% |
| 2015-06-30 | $1.06B | $-3.51B | -31.23% |
| 2015-03-31 | $1.05B | $-3.50B | -34.11% |
| 2014-12-31 | $1.05B | $-3.92B | -38.42% |
| 2014-09-30 | $1.06B | $-2.61B | -45.85% |
| 2014-06-30 | $1.06B | $-2.28B | -46.71% |
| 2014-03-31 | $1.09B | $-2.07B | -46.86% |
| 2013-12-31 | $1.11B | $-2.28B | -46.88% |
| 2013-09-30 | $1.02B | $-2.45B | -42.47% |
| 2013-06-30 | $1.02B | $-2.50B | -41.71% |
| 2013-03-31 | $1.04B | $-2.24B | -41.17% |
| 2012-12-31 | $1.19B | $-2.40B | -44.02% |
| 2012-09-30 | $1.24B | $-2.60B | -50.69% |
| 2012-06-30 | $1.25B | $-2.88B | -59.08% |
| 2012-03-31 | $1.22B | $-2.90B | -70.32% |
| 2011-12-31 | $1.07B | $-1.40B | -84.51% |
| 2011-09-30 | $1.03B | $-1.27B | -87.90% |
| 2011-06-30 | $1.00B | $-1.37B | -88.64% |
| 2011-03-31 | $0.99B | $-1.03B | -86.18% |
| 2010-12-31 | $0.98B | $-1.03B | -80.99% |
| 2010-09-30 | $0.95B | $-1.09B | -74.21% |
| 2010-06-30 | $0.93B | $-1.44B | -66.29% |
| 2010-03-31 | $0.90B | $-1.27B | -60.07% |
| 2009-12-31 | $0.89B | $-1.34B | -53.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.130B | 88.53 |
| Thermo Fisher Scientific (TMO) | United States | $161.926B | 19.59 |
| Alcon (ALC) | Switzerland | $45.995B | 31.08 |
| Edwards Lifesciences (EW) | United States | $44.288B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $40.945B | 47.06 |
| DexCom (DXCM) | United States | $32.980B | 50.98 |
| IQVIA Holdings (IQV) | United States | $26.068B | 14.60 |
| Mettler-Toledo (MTD) | United States | $24.462B | 29.09 |
| STERIS (STE) | Ireland | $22.711B | 25.97 |
| Waters (WAT) | United States | $21.365B | 30.14 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.057B | 0.00 |
| Hologic (HOLX) | United States | $12.729B | 13.83 |
| Sysmex ADR (SSMXY) | Japan | $11.601B | 0.00 |
| Penumbra (PEN) | United States | $11.465B | 89.99 |
| Masimo (MASI) | United States | $8.760B | 32.31 |
| Globus Medical (GMED) | United States | $8.012B | 18.79 |
| Teleflex (TFX) | United States | $5.603B | 9.25 |
| Glaukos (GKOS) | United States | $5.278B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.130B | 89.79 |
| PROCEPT BioRobotics (PRCT) | United States | $2.935B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.295B | 32.21 |
| Nihon Kohden (NHNKY) | Japan | $2.030B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $2.018B | 18.14 |
| Alphatec Holdings (ATEC) | United States | $1.859B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.541B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.133B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.050B | 5.58 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| SiBone (SIBN) | United States | $0.792B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.690B | 15.08 |
| IRadimed (IRMD) | United States | $0.677B | 34.34 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.588B | 9.14 |
| Beta Bionics (BBNX) | United States | $0.572B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.564B | 0.00 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.532B | 0.00 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.352B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.345B | 0.00 |
| Neuronetics (STIM) | United States | $0.293B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.91 |
| Alpha Tau Medical (DRTS) | Israel | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| 908 Devices (MASS) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.164B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| CVRx (CVRX) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |